{
  "trial_id": "NCT01200329",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, weight, height, renal function (serum creatinine clearance, serum creatinine), hepatic function (SGOT, SGPT, serum bilirubin, alkaline phosphatase), pulmonary function (FEV1, FVC, DLCO), cardiac function (left ventricular ejection fraction), Zubrod performance status, presence of B symptoms, presence of bulky disease, prior chemotherapy response, prior irradiation field relapse, number of relapses, extranodal disease at relapse, Beta HCG status in women of child-bearing potential.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "renal function (serum creatinine clearance, serum creatinine)",
          "renal function (serum creatinine clearance, serum creatinine)"
        ],
        [
          "hepatic function (SGOT, SGPT, serum bilirubin, alkaline phosphatase)",
          "hepatic function (SGOT, SGPT, serum bilirubin, alkaline phosphatase)"
        ],
        [
          "pulmonary function (FEV1, FVC, DLCO)",
          "pulmonary function (FEV1, FVC, DLCO)"
        ],
        [
          "cardiac function (left ventricular ejection fraction)",
          "cardiac function (left ventricular ejection fraction)"
        ],
        [
          "Zubrod performance status",
          "Zubrod performance status"
        ],
        [
          "Beta HCG status in women of child-bearing potential",
          "Beta HCG status in women of child-bearing potential"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Overall Study Group"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "presence of B symptoms",
        "presence of bulky disease",
        "prior chemotherapy response",
        "prior irradiation field relapse",
        "number of relapses",
        "extranodal disease at relapse"
      ]
    },
    "processed-gen-response": "Age, gender, weight, height, renal function (serum creatinine clearance, serum creatinine), hepatic function (SGOT, SGPT, serum bilirubin, alkaline phosphatase), pulmonary function (FEV1, FVC, DLCO), cardiac function (left ventricular ejection fraction), Zubrod performance status, presence of B symptoms, presence of bulky disease, prior chemotherapy response, prior irradiation field relapse, number of relapses, extranodal disease at relapse, Beta HCG status in women of child-bearing potential."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Renal Function (Serum Creatinine Clearance), Hepatic Function (SGOT, SGPT, Serum Bilirubin, Alkaline Phosphatase), Pulmonary Function (FEV1, FVC, DLCO), Cardiac Function (Left Ventricular Ejection Fraction), Zubrod Performance Status, Disease Characteristics (e.g., presence of B symptoms, bulky disease), Prior Treatment Response (e.g., response to first-line chemotherapy, relapse status),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Overall Study Group"
      ],
      "remaining_candidate_features": [
        "Renal Function (Serum Creatinine Clearance)",
        "Hepatic Function (SGOT, SGPT, Serum Bilirubin, Alkaline Phosphatase)",
        "Pulmonary Function (FEV1, FVC, DLCO)",
        "Cardiac Function (Left Ventricular Ejection Fraction)",
        "Zubrod Performance Status",
        "Disease Characteristics (e.g., presence of B symptoms, bulky disease)",
        "Prior Treatment Response (e.g., response to first-line chemotherapy, relapse status)"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Renal Function (Serum Creatinine Clearance), Hepatic Function (SGOT, SGPT, Serum Bilirubin, Alkaline Phosphatase), Pulmonary Function (FEV1, FVC, DLCO), Cardiac Function (Left Ventricular Ejection Fraction), Zubrod Performance Status, Disease Characteristics (e.g., presence of B symptoms, bulky disease), Prior Treatment Response (e.g., response to first-line chemotherapy, relapse status)"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Hodgkin's disease stage, Number of prior chemotherapy regimens, Prior radiation therapy, Presence of B symptoms, Bulky disease, Extranodal disease, Zubrod performance status, Serum creatinine, SGOT, SGPT, Serum bilirubin, Alkaline phosphatase, FEV1, FVC, DLCO, Left ventricular ejection fraction.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Overall Study Group"
      ],
      "remaining_candidate_features": [
        "Hodgkin's disease stage",
        "Number of prior chemotherapy regimens",
        "Prior radiation therapy",
        "Presence of B symptoms",
        "Bulky disease",
        "Extranodal disease",
        "Zubrod performance status",
        "Serum creatinine",
        "SGOT",
        "SGPT",
        "Serum bilirubin",
        "Alkaline phosphatase",
        "FEV1",
        "FVC",
        "DLCO",
        "Left ventricular ejection fraction"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Hodgkin's disease stage, Number of prior chemotherapy regimens, Prior radiation therapy, Presence of B symptoms, Bulky disease, Extranodal disease, Zubrod performance status, Serum creatinine, SGOT, SGPT, Serum bilirubin, Alkaline phosphatase, FEV1, FVC, DLCO, Left ventricular ejection fraction."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, weight, height, Zubrod performance status, presence of B symptoms, bulky disease, extranodal disease, prior irradiation, number of prior chemotherapy regimens, time to relapse, serum creatinine, SGOT, SGPT, serum bilirubin, alkaline phosphatase, FEV1, FVC, DLCO, left ventricular ejection fraction, CD4 count (for HIV-infected patients), HBsAg status, HBV DNA level (for hepatitis B-infected patients), hepatitis C serology, liver fibrosis stage (for hepatitis C-infected patients).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Overall Study Group",
          "Zubrod performance status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "presence of B symptoms",
        "bulky disease",
        "extranodal disease",
        "prior irradiation",
        "number of prior chemotherapy regimens",
        "time to relapse",
        "serum creatinine",
        "SGOT",
        "SGPT",
        "serum bilirubin",
        "alkaline phosphatase",
        "FEV1",
        "FVC",
        "DLCO",
        "left ventricular ejection fraction",
        "CD4 count (for HIV-infected patients)",
        "HBsAg status",
        "HBV DNA level (for hepatitis B-infected patients)",
        "hepatitis C serology",
        "liver fibrosis stage (for hepatitis C-infected patients)"
      ]
    },
    "processed-gen-response": "Age, sex, race, weight, height, Zubrod performance status, presence of B symptoms, bulky disease, extranodal disease, prior irradiation, number of prior chemotherapy regimens, time to relapse, serum creatinine, SGOT, SGPT, serum bilirubin, alkaline phosphatase, FEV1, FVC, DLCO, left ventricular ejection fraction, CD4 count (for HIV-infected patients), HBsAg status, HBV DNA level (for hepatitis B-infected patients), hepatitis C serology, liver fibrosis stage (for hepatitis C-infected patients)."
  }
}